Survival of the Exeter V40 short revision (44/00/125) stem when used in primary total hip arthroplasty
No Thumbnail Available
Authors
Evans, J. T.
Salar, O.
Whitehouse, S. L.
Sayers, A.
Whitehouse, M. R.
Wilton, T.
Hubble, M. J. W.
Issue Date
2023-05-01
Type
Journal Article
Language
eng
Keywords
Humans , *Arthroplasty, Replacement, Hip/adverse effects , *Hip Prosthesis/adverse effects , Prosthesis Design , Reoperation/adverse effects , Femur/surgery , Registries , Prosthesis Failure , Treatment Outcome , study.
Alternative Title
The Exeter V40 femoral stem is the most implanted stem in the National Joint Registry (NJR) for primary total hip arthroplasty (THA). In 2004, the 44/00/125 stem was released for use in 'cement-in-cement' revision cases. It has, however, been used 'off-label' as a primary stem when patient anatomy requires a smaller stem with a 44 mm offset. We aimed to investigate survival of this implant in comparison to others in the range when used in primary THAs recorded in the NJR. We analyzed 328,737 primary THAs using the Exeter V40 stem, comprising 34.3% of the 958,869 from the start of the NJR to December 2018. Our exposure was the stem, and the outcome was all-cause construct revision. We stratified analyses into four groups: constructs using the 44/00/125 stem, those using the 44/0/150 stem, those including a 35.5/125 stem, and constructs using any other Exeter V40 stem. In all 328,737 THAs using an Exeter V40 stem, the revision estimate was 2.8% (95% confidence interval (CI) 2.7 to 2.8). The 44/00/125 stem was implanted in 2,158 primary THAs, and the ten-year revision estimate was 4.9% (95% CI 3.6 to 6.8). Controlling for age, sex, year of operation, indication, and American Society of Anesthesiologists grade demonstrated an increased overall hazard of revision for constructs using the 44/00/125 stem compared to constructs using other Exeter V40 femoral stems (hazard ratio 1.8 (95% CI 1.4 to 2.3)). Although the revision estimate is within the National Institute for Health and Care Excellence ten-year benchmark, survivorship of constructs using the 44/00/125 stem appears to be lower than the rest of the range. Adjusted analyses will not take into account 'confounding by indication', e.g. patients with complex anatomy who may have a higher risk of revision. Surgeons and patients should be reassured but be aware of the observed increased revision estimate, and only use this stem when other implants are not suitable.
Description
Citation
Evans JT, Salar O, Whitehouse SL, Sayers A, Whitehouse MR, Wilton T, et al. Survival of the Exeter V40 short revision (44/00/125) stem when used in primary total hip arthroplasty. The bone & joint journal. 2023;105-b(5):504-10.
Publisher
British Editorial Society of Bone and Joint Journal
License
© 2023 The British Editorial Society of Bone & Joint Surgery.
Journal
The bone & joint journal